Summarized by Masters of Longevity from Peter Attia Blog.
Attia explained lab strengths and limits for disease risk and healthspan assessment.
Key Takeaways
- Blood tests are informative but provide about 25–30% of needed data.
- Sophisticated panels were reported to often lack clear clinical actionability.
- Nonblood measures and imaging are still required to assess organ health.
